Sfoglia per Titolo
[Cytostatic therapy of metastatic breast cancer]
1980-01-01 MUSSA A ;DOGLIOTTI L ;MUSUMECI SV ;LINFANTI CV ;ALABISO O ;FESTA V ;GIUGNO G ;SANDRUCCI S ;BENEDETTO G
Cytotoxic activity of a new GABA analogous.
2001-01-01 Buonerba M.; Saturnino C.; Capasso A.; Paesano N.; Barone G.; Rocco F.; Diversi E.; De Martino G.
Cytotoxic Activity of a Series of Heteroaryl-ONN-azoxysulphones and Arylsulphonylhydrazones
1989-01-01 C. Tironi; R. Fruttero; A. Di Stilo; P. Aresca; R. Bossa; I. Galatulas; M. Ninci
Cytotoxic Activity of Aryl and Heteroarylazoxy Derivatives". Anticancer Research
1989-01-01 R. Fruttero; R. Calvino; P. Aresca; R. Bossa; I. Galatulas; M. Ninci
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines.
2014-01-01 Germano A; Rapa I; Volante M; Lo Buono N; Carturan S; Berruti A; Terzolo M; Papotti M.
Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo.
2012-01-01 Catalano, Mg; Pugliese, M; Gargantini, E; Grange, C; Bussolati, B; Asioli, S; Bosco, O; Poli, R; Compagnone, A; Bandino, A; Mainini, F; Fortunati, N; Boccuzzi, G.
[Cytotoxic activity of Trichomonas vaginalis supernatants toward cellular monolayers]
1986-01-01 MARTINOTTI MG ;MERLINO C ;SAVOIA D
Cytotoxic and antiproliferative activity of the CMF regimen administered in association with tamoxifen as primary chemotherapy in breast cancer patients.
1998-01-01 BOTTINI A; BERRUTI A; BERSIGA A; BRUNELLI A; BRIZZI MP; DI MARCO B; CIRILLO F; TAMPELLINI M; BOLSI G; AGUGGINI S; BETRI E; FILIPPINI L; BERTOLI A; ALQUATI P; L. DOGLIOTTI
Cytotoxic and antiproliferative activity of the single agent epirubicin versus epirubicin plus tamoxifen as primary chemotherapy in human breast cancer: a single-institution phase III trial
2005-01-01 BOTTINI A; BERRUTI A; BRIZZI MP; BERSIGA A; GENERALI D; ALLEVI G; AGUGGINI S; BOLSI G; BONARDI S; TONDELLI B; VANA F; TAMPELLINI M; ALQUATI P; DOGLIOTTI L
Cytotoxic and proinflammatory responses induced by ZnO nanoparticles in in vitro intestinal barrier
2019-01-01 Colombo G.; Cortinovis C.; Moschini E.; Bellitto N.; Perego M.C.; Albonico M.; Astori E.; Dalle-Donne I.; Bertero A.; Gedanken A.; Perelsthein I.; Mantecca P.; Caloni F.
Cytotoxic and transforming effects of silica particles with different surface properties in of Syrian hamster embryo (SHE) cells
2000-01-01 Z. ELIAS; O. POIROT; M.C. DANIRE; F. TERZETTI; A.M. MARANDE; S. DZWIGAJ; H. PEZERAT; I. FENOGLIO; B. FUBINI
Cytotoxic chemotherapy for adrenocortical carcinoma.
1995-01-01 L. DOGLIOTTI; BERRUTI A; PIA A; PACCOTTI P; ALÌ A; ANGELI A
Cytotoxic chemotherapy in advanced non-small cell lung cancer.
2005-01-01 SCAGLIOTTI GV ;NOVELLO S ;SELVAGGI G
Cytotoxic effect of Camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo in orthotopic xenograft tumors
2015-01-01 Ferrara, B; Gigliotti, L; Occhipinti, S; Boggio, E; Barrera, G; Pizzimenti, S; Giovarelli, M; Fantozzi, R; Chiocchetti, A; Trotta, F; Dianzani, U; Cavalli, R; Dianzani, C
Cytotoxic effect of Camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in orthotopic xenograft tumors in vivo
2015-01-01 Ferrara, B; Gigliotti, L; Occhipinti, S; Boggio, E; Barrera, G; Pizzimenti, S; Giovarelli, M; Fantozzi, R; Chiocchetti, A; Trotta, F; Dianzani, U; Cavalli, R; Dianzani, C
Cytotoxic effect of trabectedin in human adrenocortical carcinoma cell lines and primary cells
2020-01-01 Abate A.; Rossini E.; Bonini S.A.; Fragni M.; Cosentini D.; Tiberio G.A.M.; Benetti D.; Hantel C.; Lagana M.; Grisanti S.; Terzolo M.; Memo M.; Berruti A.; Sigala S.
Cytotoxic effects of oxytetracycline residues in the bones of broiler chickens following therapeutic oral administration of a water formulation
2015-01-01 Odore, R; De Marco, M; Gasco, L; Rotolo, L; Meucci, V; Palatucci, A T; Rubino, V; Ruggiero, G; Canello, S; Guidetti, G; Centenaro, S; Quarantelli, A; Terrazzano, G; Schiavone, A
Cytotoxic Effects of p -Cresol in Renal Epithelial Tubular Cells
2013-01-01 A. Brocca; G.M. Virzì; M. de Cal; V. Cantaluppi; C. Ronco
Cytotoxic pathways activated by multifunctional thiosemicarbazones targeting sigma-2 receptors in breast and lung carcinoma cells
2023-01-01 Kopecka, Joanna; Barbanente, Alessandra; Vitone, Daniele; Arnesano, Fabio; Margiotta, Nicola; Berchialla, Paola; Niso, Mauro; Riganti, Chiara; Abate, Carmen
Cytotoxic properties of clofibrate and other peroxisome proliferators: relevance to cancer progression
2010-01-01 Penna F.; Bonelli G.; Baccino F.M.; Costelli P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| [Cytostatic therapy of metastatic breast cancer] | 1980 | MUSSA A ;DOGLIOTTI L ;MUSUMECI SV ;LINFANTI CV ;ALABISO O ;FESTA V ;GIUGNO G ;SANDRUCCI S ;BENEDETTO G | |
| Cytotoxic activity of a new GABA analogous. | 2001 | Buonerba M.; Saturnino C.; Capasso A.; Paesano N.; Barone G.; Rocco F.; Diversi E.; De Martino G. | |
| Cytotoxic Activity of a Series of Heteroaryl-ONN-azoxysulphones and Arylsulphonylhydrazones | 1989 | C. Tironi; R. Fruttero; A. Di Stilo; P. Aresca; R. Bossa; I. Galatulas; M. Ninci | |
| Cytotoxic Activity of Aryl and Heteroarylazoxy Derivatives". Anticancer Research | 1989 | R. Fruttero; R. Calvino; P. Aresca; R. Bossa; I. Galatulas; M. Ninci | |
| Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. | 2014 | Germano A; Rapa I; Volante M; Lo Buono N; Carturan S; Berruti A; Terzolo M; Papotti M. | |
| Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo. | 2012 | Catalano, Mg; Pugliese, M; Gargantini, E; Grange, C; Bussolati, B; Asioli, S; Bosco, O; Poli, R; Compagnone, A; Bandino, A; Mainini, F; Fortunati, N; Boccuzzi, G. | |
| [Cytotoxic activity of Trichomonas vaginalis supernatants toward cellular monolayers] | 1986 | MARTINOTTI MG ;MERLINO C ;SAVOIA D | |
| Cytotoxic and antiproliferative activity of the CMF regimen administered in association with tamoxifen as primary chemotherapy in breast cancer patients. | 1998 | BOTTINI A; BERRUTI A; BERSIGA A; BRUNELLI A; BRIZZI MP; DI MARCO B; CIRILLO F; TAMPELLINI M; BOLSI G; AGUGGINI S; BETRI E; FILIPPINI L; BERTOLI A; ALQUATI P; L. DOGLIOTTI | |
| Cytotoxic and antiproliferative activity of the single agent epirubicin versus epirubicin plus tamoxifen as primary chemotherapy in human breast cancer: a single-institution phase III trial | 2005 | BOTTINI A; BERRUTI A; BRIZZI MP; BERSIGA A; GENERALI D; ALLEVI G; AGUGGINI S; BOLSI G; BONARDI S; TONDELLI B; VANA F; TAMPELLINI M; ALQUATI P; DOGLIOTTI L | |
| Cytotoxic and proinflammatory responses induced by ZnO nanoparticles in in vitro intestinal barrier | 2019 | Colombo G.; Cortinovis C.; Moschini E.; Bellitto N.; Perego M.C.; Albonico M.; Astori E.; Dalle-Donne I.; Bertero A.; Gedanken A.; Perelsthein I.; Mantecca P.; Caloni F. | |
| Cytotoxic and transforming effects of silica particles with different surface properties in of Syrian hamster embryo (SHE) cells | 2000 | Z. ELIAS; O. POIROT; M.C. DANIRE; F. TERZETTI; A.M. MARANDE; S. DZWIGAJ; H. PEZERAT; I. FENOGLIO; B. FUBINI | |
| Cytotoxic chemotherapy for adrenocortical carcinoma. | 1995 | L. DOGLIOTTI; BERRUTI A; PIA A; PACCOTTI P; ALÌ A; ANGELI A | |
| Cytotoxic chemotherapy in advanced non-small cell lung cancer. | 2005 | SCAGLIOTTI GV ;NOVELLO S ;SELVAGGI G | |
| Cytotoxic effect of Camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo in orthotopic xenograft tumors | 2015 | Ferrara, B; Gigliotti, L; Occhipinti, S; Boggio, E; Barrera, G; Pizzimenti, S; Giovarelli, M; Fantozzi, R; Chiocchetti, A; Trotta, F; Dianzani, U; Cavalli, R; Dianzani, C | |
| Cytotoxic effect of Camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in orthotopic xenograft tumors in vivo | 2015 | Ferrara, B; Gigliotti, L; Occhipinti, S; Boggio, E; Barrera, G; Pizzimenti, S; Giovarelli, M; Fantozzi, R; Chiocchetti, A; Trotta, F; Dianzani, U; Cavalli, R; Dianzani, C | |
| Cytotoxic effect of trabectedin in human adrenocortical carcinoma cell lines and primary cells | 2020 | Abate A.; Rossini E.; Bonini S.A.; Fragni M.; Cosentini D.; Tiberio G.A.M.; Benetti D.; Hantel C.; Lagana M.; Grisanti S.; Terzolo M.; Memo M.; Berruti A.; Sigala S. | |
| Cytotoxic effects of oxytetracycline residues in the bones of broiler chickens following therapeutic oral administration of a water formulation | 2015 | Odore, R; De Marco, M; Gasco, L; Rotolo, L; Meucci, V; Palatucci, A T; Rubino, V; Ruggiero, G; Canello, S; Guidetti, G; Centenaro, S; Quarantelli, A; Terrazzano, G; Schiavone, A | |
| Cytotoxic Effects of p -Cresol in Renal Epithelial Tubular Cells | 2013 | A. Brocca; G.M. Virzì; M. de Cal; V. Cantaluppi; C. Ronco | |
| Cytotoxic pathways activated by multifunctional thiosemicarbazones targeting sigma-2 receptors in breast and lung carcinoma cells | 2023 | Kopecka, Joanna; Barbanente, Alessandra; Vitone, Daniele; Arnesano, Fabio; Margiotta, Nicola; Berchialla, Paola; Niso, Mauro; Riganti, Chiara; Abate, Carmen | |
| Cytotoxic properties of clofibrate and other peroxisome proliferators: relevance to cancer progression | 2010 | Penna F.; Bonelli G.; Baccino F.M.; Costelli P. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile